What is Regenxbio's restricted cash?

Regenxbio (RGNX) reported restricted cash of $2.03M in Q1 2026.

How has Regenxbio's restricted cash changed year-over-year?

Regenxbio's restricted cash decreased by 0.0% year-over-year, from $2.03M to $2.03M.

What is the long-term trend for Regenxbio's restricted cash?

Over 5 years (2020 to 2025), Regenxbio's restricted cash has grown at a 8.8% compound annual growth rate (CAGR), from $1.33M to $2.03M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Regenxbio RGNX Restricted Cash

Restricted Cash at other companies

EyePoint, Inc. EYPT

$150K0.0%

Solid Biosciences Inc.SLDB

$638K—

XencorXNCR

$191K-32.7%

Sutro BiopharmaSTRO

$858K0.0%

Regeneron PharmaceuticalsREGN

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsNoncurrent.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's restricted cash?: Regenxbio (RGNX) reported restricted cash of $2.03M in Q1 2026.
How has Regenxbio's restricted cash changed year-over-year?: Regenxbio's restricted cash decreased by 0.0% year-over-year, from $2.03M to $2.03M.
What is the long-term trend for Regenxbio's restricted cash?: Over 5 years (2020 to 2025), Regenxbio's restricted cash has grown at a 8.8% compound annual growth rate (CAGR), from $1.33M to $2.03M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.